Close Window

Digital Look Email A Friend

Biogen ups forecasts despite weak Alzheimer's drug sales

Published by Abigail Townsend on 20th October 2021

(Sharecast News) - Biogen raised its full-year earnings guidance on Wednesday, despite weak sales of breakthrough Alzheimer's drug Aduhelm.

URL: http://www.digitallook.com/dl/news/story/32206080/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.